Functions and Health Benefits of Conjugated Linoleic Acid: A Review of Controlled Clinical Trials
Introduction: The term “Conjugated linoleic acid (CLA)” refers to a class of linoleic acid isomers. During the recent years, scientists have particularly regarded this fatty acid as a functional food. However, the findings of the studies in health benefits of CLA are inconsistent. The purpose of this study was to review the articles that investigated the effects of CLA on different aspects of health.
Materials and Methods: Controlled clinical trials including human, animal and in vitro studies having been published since 2000 till 2016 in English were searched in PubMed, ISI Web of Science, Scopus and Science Direct databases. Sixty four articles were finally selected to review the results.
Results: Findings of the researche indicated that CLA has an anticarcinogenic function. In some studies CLA had beneficial effects on bone metabolism and it is suggested that CLA may be useful in prevention and treatment of osteoporosis. In addition supplementation with CLA in animal and human models leaded to reduction in body fat mass and improvement in insulin resistance and lipid profile. However, some studies reported adverse effects of CLA intake including accumulation of fat in tissues, elevation of lipid peroxidation and inflammation markers.
Conclusion: Although benefits of CLA intake are shown in several studies, side effects of this fatty acid are reported in other researche. It is necessary to design further studies to more precise investigation of the benefits and risks of CLA.
Keywords: Conjugated linoleic acid, Health, review
Wahle KW, Heys SD, RotondoD. Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res. 2004;43(6):553-87.
Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects. Eur J Clin Nutr. 2003;57(10):1268-74.
Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17(12):789-810.
Pariza MW, Ashoor SH, Chu FS, Lund DB. Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 1979;7:63-9.
Warren JM, Simon VA, Bartolini G, Erickson KL, Mackey BE, Kelley DS. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids. 2003;38(5):497-504.
Rahman SM, Wang Y, Yotsumoto H, Cha J, Han S, Inoue S, et al. Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition. 2001;17(5):385-90.
Hargrave KM, Li C, Meyer BJ, Kachman SD, Hartzell DL, Della-Fera MA, et al. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes Res. 2002;10(12):1284–90.
Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999;34(3):235-41.
Halade GV, Rahman MM, Fernandes G. Differential effects of conjugated linoleic acid isomers in insulin-resistant female C57Bl/6J mice. J Nutr Biochem. 2010;21(4):332-7.
Terpstra AH, Beynen AC, Everts H, Kocsis S, Katan MB, Zock PL. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. J Nutr. 2002;132(5):940-5.
Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000;49(9):1534-42.
West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol.1998;275:R667-72.
Sisk MB, Hausman DB, Martin RJ, Azain MJ. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr. 2001;131(6):1668-74.
Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, et al. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr. 2007;97(3):550-60.
Chen SC, Lin YH, Huang HP, Hsu WL, Houng JY, Huang CK. Effect of conjugated linoleic acid supplementation on weight loss and body fat composition in a Chinese population. Nutrition. 2012;28(5):559-65.
Racine NM, Watras AC, Carrel AL, Allen DB, McVean JJ, Clark RR, et al. Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr. 2010;91(5):1157-64.
Carvalho RF, Uehara SK, Rosa G. Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome. Vasc Health Risk Manag. 2012;8:661-7.
Risérus U, Basu S, Jovinge S, Fredrikson GN, Arnlöv J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002;106(15):1925-9.
Joseph SV, Jacques H, Plourde M, Mitchell PL, McLeod RS, Jones PJ. Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr. 2011;141(7):1286-91.
Deguire JR, Makarem N, Vanstone CA, Morin S, Duque G, Weiler HA. Conjugated linoleic acid is related to bone mineral density but does not affect parathyroid hormone in men. Nutr Res. 2012;32(12):911-20.
Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects. Lipids. 2001;36(8):773-81.
Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res. 2001;29(5):392-6.
Norris LE, Collene AL, Asp ML, Hsu JC, Liu LF, Richardson JR, et al. Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr. 2009;90(3):468-76.
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130(12):2943-8.
Shadman Z, Taleban FA, Saadat N, Hedayati M. Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics. J Diabetes Metab Disord. 2013;12(1):42.
Kelley DS, Erickson KL. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks. Lipids. 2003;38(4):377-86.
Cho K, Song Y1, Kwon D. Conjugated linoleic acid supplementation enhances insulin sensitivity and peroxisome proliferator‐activated receptor gamma and glucose transporter type 4 protein expression in the skeletal muscles of rats during endurance exercise. Iran J Basic Med Sci. 2016;19(1):20-7.
Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes. 2001;50(5):1149-57.
Zhou XR, Sun CH, Liu JR, Zhao D. Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res. 2008;18(5):361-8.
Go G, Wu G, Silvey DT, Choi S, Li X, Smith SB. Lipid metabolism in pigs fed supplemental conjugated linoleic acid and/or dietary arginine. Amino Acids. 2012;43(4):1713-26.
Aminot-Gilchrist DV, Anderson HD. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Am J Clin Nutr. 2004;79(6 Suppl):1159S-1163S.
Risérus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25(9):1516-21.
Poirier H, Shapiro JS, Kim RJ, Lazar MA. Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes. 2006;55(6):1634-41.
Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80(4):887-95.
Thrush AB, Chabowski A, Heigenhauser GJ, McBride BW, Or-Rashid M, Dyck DJ. Conjugated linoleic acid increases skeletal muscle ceramide content and decreases insulin sensitivity in overweight, non-diabetic humans. Appl Physiol Nutr Metab. 2007;32(3):372-82.
Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc. 2004;36(5):814-20.
Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 1994;108(1):19-25.
Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr. 2000;130(1):27-9.
Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord. 2003;27(7):840-7.
Thomas Yeung CH, Yang L, Huang Y, Wang J, Chen ZY. Dietary conjugated linoleic acid mixture affects the activity of intestinal acyl coenzyme A: cholesterol acyltransferase in hamsters. Br J Nutr. 2000;84(6):935-41.
Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr. 2002;88(3):243-51.
Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E, et al. Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr. 2006;83(4):744-53.
Basu S, Risérus U, Turpeinen A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (Lond). 2000;99(6):511-6.
Basu S, Smedman A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett. 2000;468(1):33-6.
Smedman A, Vessby B, Basu S. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond). 2004;106(1):67-73.
Raff M, Tholstrup T, Basu S, Nonboe P, Sørensen MT, Straarup EM. A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J Nutr. 2008;138(3):509-14.
Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med. 1996;334(6):356-61.
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 1994;54(9):2390-7.
Yang H, Stuart GR, Glickman BW, de Boer JG. Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr Cancer. 2001;39(2):259-66.
Park HS, Ryu JH, Ha YL, Park JH. Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr. 2001;86(5):549-55.
Mohammadzadeh M, Faramarzi E, Mahdavi R, Nasirimotlagh B, Asghari Jafarabadi M. Effect of Conjugated Linoleic Acid Supplementation on Inflammatory Factors and Matrix Metalloproteinase Enzymes in Rectal Cancer Patients Undergoing Chemoradiotherapy. Integr Cancer Ther. 2013;12(6):496-502.
Amarù DL, Biondo PD, Field CJ. The Role of Conjugated Linoleic Acid in Breast Cancer Growth and Development. Open Nutraceuticals J. 2010;3:30-46.
Białek A, Tokarz A, Zagrodzki P. Conjugated linoleic acids (CLA) decrease the breast cancer risk in DMBA-TREATED rats. Acta Pol Pharm. 2016;73(2):315-27.
McGowan MM, Eisenberg BL, Lewis LD, Froehlich HM, Wells WA, Eastman A, et al. A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue. Breast Cancer Res Treat. 2013;138(1):175-83.
Li D, Yang K, Li JS, Ke XY, Duan Y, Du R, et al. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings. Int J Nanomedicine. 2012;7:6105-14.
Kuniyasu H, Yoshida K, Sasaki T, Sasahira T, Fujii K, Ohmori H. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Int J Cancer. 2006;118(3):571-6.
Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD, Wahle KW. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis. 2004;25(7):1185-91.
Palombo JD, Ganguly A, Bistrian BR, Menard MP. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett. 2002;177(2):163-72.
Ip C, Dong Y, Ip MM, Banni S, Carta G, Angioni E, Murru E, et al. Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer. 2002;43(1):52-8.
Watkins BA, Li Y, Lippman HE, Reinwald S, Seifert MF. A test of Ockham's razor: implications of conjugated linoleic acid in bone biology. Am J Clin Nutr. 2004;79(6 Suppl):1175S-1185S.
Kelly O, Cashman KD. The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. Prostaglandins Leukot Essent Fatty Acids. 2004;71(5):295-301.
Park Y, Terk M, Park Y. Interaction between dietary conjugated linoleic acid and calcium supplementation affecting bone and fat mass. J Bone Miner Metab. 2011;29(3):268-78.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Medical Reviews is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.